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Article

Gene electrotransfer enhanced by nanosecond pulsed electric
fields
Siqi Guo1, Diane L Jackson1, Niculina I Burcus1, Yeong-Jer Chen1, Shu Xiao1 and Richard Heller1

The impact of nanosecond pulsed electric fields (nsPEFs) on gene electrotransfer has not been clearly demonstrated in previous
studies. This study was conducted to evaluate the influence of nsPEFs on the delivery of plasmids encoding luciferase or green
fluorescent protein and subsequent expression in HACAT keratinocyte cells. Delivery was performed using millisecond electric
pulses (msEPs) with or without nsPEFs. In contrast to reports in the literature, we discovered that gene expression was significantly
increased up to 40-fold by applying nsPEFs to cells first followed by one msEP but not in the opposite order. We demonstrated
that the effect of nsPEFs on gene transfection was time restricted. The enhancement of gene expression occurred by applying one
msEP immediately after nsPEFs and reached the maximum at posttreatment 5 minutes, slightly decreased at 15 minutes and had
a residual effect at 1 hour. It appears that nsPEFs play a role as an amplifier without changing the trend of gene expression kinetics
due to msEPs. The effect of nsPEFs on cell viability is also dependent on the specific pulse parameters. We also determined that
both calcium independent and dependent mechanisms are involved in nsPEF effects on gene electrotransfer.
Molecular Therapy — Methods & Clinical Development (2014) 1, 14043; doi:10.1038/mtm.2014.43; published online 17 September 2014

INTRODUCTION
Gene electrotransfer (GET) or gene transfer mediated by electric
fields is a simple, direct, versatile physical method and low cost
gene delivery approach. It has been broadly utilized for in vitro
and in vivo gene delivery.1–6 GET has been tested in preclinical
and clinical trials to treat cancer7 and several systemic disorders,8,9
deliver DNA vaccines,10,11 improve wound healing12,13 as well as
several other applications. While many clinical trials have been
initiated and completed, one particular concern is its efficacy and
adverse effects. The enhancement of GET efficiency will make it
more attractive to clinical translation and broaden the potential
applications. Although many efforts have been made to improve
the efficiency of GET,14–18 one big issue is the decrease of cell or
tissue viability.
The transition of the use of high power pulse technology to
the biomedical field is dependent on the evaluation of the effect
nanosecond pulsed electric fields (nsPEFs)19 on biological systems. Modeling studies showed that nsPEFs has a greater impact
on intracellular organelles than microsecond pulses.20,21 The biological effects of nsPEFs vary from cell function modulation to cell
death. Low doses of nsPEFs have been shown to permeabilize the
plasma membrane at a comparatively low energy dose22 compared
to typical electroporetic parameters. Previous research has demonstrated that both plasma and organelle membranes become
permeabilized to small ions following exposure to nsPEFs.23,24 The
intracellular effects of nsPEFs include disruption of intracellular
vesicles,24,25 release of calcium from endoplasmic reticulum,26,27 and

immediate and prolonged loss of mitochondrial membrane potential.28 Previous studies on the application of nsPEFs have focused
on delivering lethal doses, or nsPEF ablation. High doses of nsPEFs
induce apoptosis in mammalian cells and tissues.29,30 Both hematologic and solid tumor cell lines have demonstrated decreased viability following high dose nsPEF treatment.31 Localized nsPEF delivery
has demonstrated complete local remission without recurrence in
an in vivo melanoma mouse model.32 A recent study reported delivery of a siRNA molecule with nsPEFs;33 however, to date there has
not been success in delivering plasmids. Since nsPEFs can influence
intracellular events including disruption of nuclear envelope and
cytoskeleton it may affect the efficiency of DNA delivery to nucleus.
Two groups of investigators34,35 have evaluated this issue by following a similar protocol but lead to controversial conclusions. Beebe
et al.34,36 showed that GFP expression could be increased about four
times the levels achieved with classical millisecond electric pulse
(msEP) when cells were exposed to 1 msEP then 1 nsPEF 30 minutes later. In contrast, Chopinet et al.35 concluded that nsPEFs had
no effect on GET by following the same order but with more sets of
msEP and nsPEF parameters.
In this study, we first assessed the effect of nsPEFs on GET with
classical msEPs. After we discovered that pretreatment with nsPEFs
could synergize with GET to dramatically increase gene expression,
we then characterized the properties of nsPEF effect, such as its’
influence on kinetic gene expression, cell viability and the impact of
interval between two pulses. We also explored the potential role of
calcium on the effect of nsPEFs as a possible mechanism.
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RESULTS
Effects of nsPEFs on the cell viability of electrotransfer
One important issue we wanted to address was whether cells
pretreated with nsPEFs could result in additional cell death. Cell
viability was decreased proportionally after applied electric field
was above 70 V for 1 msEP alone (Figure 1). Cells pretreated with
nsPEFs amplified this influence. However, no additional cell death
would be induced if no cell death occurred with 1 msEP alone with
applied electric field below 70 V (Figure 1). This result was associated
with particular parameters of nsPEFs, 24 KV/cm of applied electric
field, 60 ns of pulse duration, 1 Hz of frequency, and 23 pulses. If
the applied electric field was increased to 32 KV/cm without change
of other parameters of nsPEFs, cell death would be observed even
combined with 1 msEP at 50 V of applied electric field. Obviously,
both parameters of msEPs and nsPEFs were critical to determine
cell viability. Cell death could occur or increase if pulse number
and/or electric field strength of either electric pulse(s) reached
certain threshold or above. To minimize cell death and maximize
gene expression, both parameters of msEPs and nsPEFs should be
optimized.

Enhanced electrotransfer efficiency by nsPEFs
Although it was reported that GFP expression was enhanced when
nsPEFs was applied after msEPs in previous reports,34,36 we have
not observed any significant increase of luciferase expression of
HACAT cells while similar parameters and the same order of two
electroporations were adopted (Figure 2a). On the contrary, significant increase of gene expression was obtained while nsPEFs were
applied prior to msEPs (Figures 2b and 3). The luciferase expression
resulting from the combined electric pulses was enhanced two- to
fourfold compared to 1 msEP alone dependent on the electric field
strength of nsPEFs (Figure 2b, 12–24 KV/cm). The increase of gene
expression was positively correlated with both electric field strength
(Figures 2b and 3d) and pulse number (Figure 3c) of nsPEFs. Under
the same parameters of nsPEFs, the percentage of GFP expression
could be enhanced three- to tenfold dependent on the applied
electric field strength of 1 msEP from 50 to 100 V (Figure 3). The fluorescence intensity of GFP was two- to threefold higher for the combined pulses than for one millisecond pulse alone. However, those
results did not mean the total expression was increased to the same
extent, because more cell death was observed along with higher
electric field of millisecond pulses (Figure 1).

120

Kinetic gene expression with GET enhanced by nsPEFs
We further addressed if cells pretreated with nsPEFs could change
the kinetics of gene expression by msEPs. Utilizing the IVIS Spectrum
system, luciferase expression was evaluated at different time points
with the same transfected cells. Two kinetic models of gene expression were found after GET with/without nsPEFs. Under parameters
not causing cell death, in this case there were 5 ms of pulse duration
and 50 V of applied electric field for 1 msEP with or without 60 ns
of pulse duration, 24 KV/cm of electric field strength, 1 Hz of frequency, and 23 pulses for nsPEFs (Figure 4). Gene expression with
1 msEP alone or combined with nsPEFs was the highest at day 1
and rapidly dropped to the background level at day 4. Compared
to 1 msEP alone, the nsPEFs enhanced gene expression about four
times (Figure 4a). On the other hand, using parameters that cause
death of majority of cells (Figure 1), applied electric field of 130 V
for 1 msEP without change of other electrical parameters, gene
expression reached the highest at day 1 and dropped in 8 days but

msEP

100

60
40
20
0
40

50

60

70

90

110

130

Figure 1 Viability of HACAT cells after gene electrotransfer (GET). msEP:
1 msEP with applied electric field 40–130 V. Comb: treated with nsPEFs
then 5 minutes later with 1 msEP. nsPEF parameters: 60 ns, 24 KV/cm, 1
Hz, and 23 pulses; msEP parameters: 5 ms, 1 pulse, applied electric field
as indicated. Error bars represent SD.

b
Luciferase expression (pg)

1.0 × 108

7

1.0 × 10

1.0 × 106

1.0 × 105

16

*

14
12
10

*

8
6

*

4
2

2K
V
om
C

-1
om
C

-2
om
C

-1

6K
V

V
4K

P
sE
m

Ps
ns
PE

b60

15

om
C

5

om
bC

b-

0
b-

om
C

om
C

Fs
PE

C

ns

sE
P

0

tr

1.0 × 10

4

m

Luciferase expression (p/s)

a

tr

Ctr

C

Viability (%)

Comb
80

Figure 2 Luciferase expression after combination pulses. (a) luciferase expression of HACAT cells 1 day after gene electrotransfer (GET) with gWIZluc. Ctr: plasmid alone; nsPEFs: nsPEFs with pulse duration 60 ns, 24 KV/cm, 1 Hz, and 23 pulses; msEP: 1 msEP with pulse duration 5 ms and applied
electric field 70 V; Comb-0, 5, 15, 60: treated with 1 msEP then followed by nsPEFs with time interval 0, 5, 15, and 60 minutes, respectively. (b) luciferase
expression (pg/million cells) of HACAT cells 1 day after GET with gWIZ-luc. Ctr: plasmid alone; nsPEFs: nsPEFs with pulse duration 60 ns, 24 KV/cm, 1
Hz, and 23 pulses; msEP: 1 msEP with pulse duration 5 ms and applied electric field 50 V; Comb-12, 16, and 24 KV: pretreated with nsPEFs with electric
field 12, 16, and 24 KV/cm, respectively then 5 minutes later followed by 1 msEP. Error bars represent SD. n = 8–12, *P < 0.001 for Combination groups
versus msEP.
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Figure 3 GFP expression after combination pulses. GFP expression of HACAT cells by flow cytometry after gene electrotransfer (GET) with comb-pulses
and plasmid gWIZ-GFP. For A, B and C, Ctr: plasmid alone; nsPEFs: pulse duration 60 ns, 32 KV/cm, 1 Hz, and 23 pulses; msEP: pulse duration 5 ms, 1 pulse
and applied electric field as indicated. Comb: pretreated with nsPEFs 5 minutes followed by 1 msEP. (a) Histogram of GFP expression. msEP −80 or 100:
1 msEP with applied electric field 80 V or 100 V. (b) Mean Flurorescence Intensity (MFI) of GFP expression. (c) Percentage of GFP positive cells. Comb-a:
16 pulses of nsPEFs; Comb-b: 23 pulses of nsPEFs. (d) Percentage of GFP transfected cells. Ctr: plasmid alone; nsPEFs: pulse duration 60 ns, 24 KV/cm, 1
Hz, and 23 pulses; msEP: pulse duration 5 ms, 1 pulse and applied electric field 50 V. Comb-12, 16, and 24 KV: pretreated with nsPEFs with electric field
12, 16, and 24 KV/cm, respectively, 5 minutes later followed by 1 msEP. Error bars represent SD.
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Figure 4 Kinetics of gene expression of HACAT cells after gene electrotransfer (GET). (a,b) Luciferase expression of HACAT cells after GET with gWIZLuc. Groups, Ctr: plasmid alone. nsPEFs: treated with nsPEFs alone. ms-50, 130: treated with 1 msEP applied electric field 50 V or 130 V. Comb-50, 130:
treated with nsPEFs then 5 minutes later with 1 msEP applied electric field 50 V or 130 V. nsPEF Parameters: 60 ns, 24 KV/cm, 1 Hz, and 23 pulses; msEP
parameters: 5 ms, 1 pulse, applied electric field as indicated. Error bars represent SD.

did not drop to background levels even after 18 days after transfection either with 1 msEP alone or with nsPEFs. In contrast to 1 msEP
alone, the nsPEFs enhanced gene expression 1.7–2.8 times at different time points (Figure 4b). If we consider more cell death for the
© 2014 The American Society of Gene & Cell Therapy

combined pulses than that for 1 msEP alone, the increase of expression on a per cell basis could reach 15-fold at day 1. For both kinetic
models of gene expression, nsPEFs plays a role as an amplifier without changing the trend of gene expression due to msEPs.
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By direct observation of GFP expression under fluorescence
microscopy, GFP positive cells showed heterogeneous fluorescence
intensity and diverse kinetics (Figure 5). HACAT cells with high
fluorescence intensity could either rapidly drop GFP expression
to background level in 4 days or maintain high expression longer
than 4 days while cells were dividing. Meantime, cells with lower
fluorescence intensity could maintain GFP expression at least 4
days. In contrast to results from live imaging of luciferase expression
(Figure 4b), GFP expression lasted at least 9 days (Supplementary
Figure S1). Although the half-life of GFP in HACAT cells was not
determined precisely here, studies in human colon adenocarcinoma cells have shown a half-life of 28.3 hours.37 A problem for the

Comb-90, d1

Comb-90, d3

200 µm
Comb-90, d2

200 µm

observation of long-term GFP expression is that cells were fused
together and might go through aging or degradation.
Time-restricted effects of nsPEFs on GET
Besides the order of millisecond and nanosecond electric pulses
having a significant impact on gene expression efficiency (Figure 2),
we also discovered that the effect of nsPEFs on gene transfection
was time restricted. The enhancement of gene expression occurred
immediately after nsPEFs and reached the maximum at posttreatment 5 minutes, slightly reduced at 15 minutes and had a residual
effect at 1 hour (Figure 6a). Under the parameters we adopted in
this experiment, in contrast to 1 msEP alone, luciferase expression
with combined pulses was increased to 20.3-fold, 43.5-fold, 37.9fold, and 9.5-fold (all P < 0.001), respectively for time gap 0 minute, 5
minutes, 15 minutes, and 1 hour. For this reason, we performed GET
after cells pulsed with nsPEFs 5 minutes for all experiments except
with these time-restricted assays. The extent of gene expression
increase after cells pretreated with nsPEFs may vary depending on
the parameters of nsPEFs and msEPs. For example, under another
set of parameters, luciferase expression with combined pulses was
enhanced to 3.4-fold, 6.5-fold, and, 6.1-fold, (all P < 0.001), respectively for the same time gaps as above (Figure 6b).

Comb-90, d4

200 µm

200 µm

Figure 5 Diverse GFP expression and dynamic changes. Images of HACAT
cells after gene electrotransfer (GET) with combination pulses. Comb90: cells pretreated with nsPEFs 5 minutes followed by 1 msEP. nsPEF
parameters: pulse duration 60 ns, 24 KV/cm, 1 Hz, and 23 pulses; msEP
parameters: pulse duration 5 ms, applied electric field 90 V and 1 pulse.
Day 1 (d1), d2, d3, and d4: images with the same area were taken after
GET 1, 2, 3, and 4 days.

a

The role of calcium on nsPEFs’ effect on gene expression
Calcium release induced by nsPEFs has been reported by several
groups.26,27 To address whether extracellular calcium plays a role on
the effects of nsPEFs on GET, we performed experiments by replacing complete medium (DMEM with 10% FBS) with calcium free PBS
(Dulbecco’s Phosphate Buffered Saline). Surprisingly, gene expression from both 1 msEP alone and combination pulses was dramatically reduced (Figure 7a, b). However, the significant enhancement
effects were still present by combination with nsPEFs. In contrast
to 1 msEP alone, luciferase expression with combined pulses was
increased to 2.6-fold, 3.5-fold, and 3.4-fold (all P < 0.001), respectively
for time gap 0 minute, 5 minutes, and 15 minutes (Figure 7b). To
assess the role of intracellular calcium on the nsPEF enhancement,
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HACAT cells suspended in calcium free DMEM were pretreated with
cyclopiazonic acid (CPA) at 20 µmol/l for 30 minutes then performed
the experiment as above. Although immediate enhancement of
nsPEFs was observed, the time-restrictive changes of nsPEFs within
1 hour were blocked by intracellular calcium depletion. Compared
to 1 msEP alone, luciferase expression with combined pulses was
increased to 2.4-fold, 2.2-fold, 2.1-fold, and 2.6-fold (all P < 0.05),
respectively for time gap 0 minute, 5 minutes, 15 minutes, and 1
hour (Figure 7c).
DISCUSSION
In comparison to viral gene delivery system, one of the disadvantages for non-viral delivery is low efficiency. To enhance delivery
a variety of approaches have been developed including physical
methods. One method that has shown a great deal of potential is
electro transfer. At least two strategies have been developed for
the improvement of GET efficiency. One is the optimization of various influencing factors including DNA concentration, electrodes
and pulse parameters (field strength, field direction, pulse number
and frequency). Another is the enhancement of GET with other factors that do not deliver DNA but may synergize with GET.15–17 Our
present approach is one example of second strategy since nsPEFs
alone do not sufficiently deliver plasmid DNA into cells. Our results
clearly demonstrated that pretreating cells with nsPEFs could significantly enhance the efficiency of GET with both mild and intense
msEP parameters. However, no major impact on gene expression,
which is consistent with Chopinet’s report,35 was observed if cells
© 2014 The American Society of Gene & Cell Therapy

were treated with msEPs first and nsPEFs later. This is against our
initial hypothesis that nsPEFs would facilitate transport of the DNA
from the cell membrane to the nucleus after classical electroporation. The mechanism why the order of two electric pulses is critical
to influence gene expression is unclear. Noticeably, it appears that
nsPEFs can amplify the effects of msEPs whether it’s on gene expression or on cell damage. This property could be potentially utilized to
enhance GET efficiency or improve the efficacy of irreversible electroporation (IRE).
Cell viability is critical for GET to treat metabolic diseases, inoculate vaccines, etc. A common issue for the enhancement of GET
is concomitant additional cell damage or cell death. Additional
cytotoxicity with 80% or 50% cell death38 was present while antioxidant vitamin C (6–8 mmol/l) or tempol (8 mmol/l) was utilized to
increase GET efficiency. Cemazar et al.15 reported that pretreatment
of tumors with a combination of hyaluronidase and collagenase can
significantly enhance GET efficiency. However, the tumor growth
with combination enzymes and GET was observed slower than control or GET alone group within 5 days.15 Our viability study showed
that the enhanced efficiency of GET without cause of cell death can
be achieved by optimizing both pulse parameters. This feature indicates the possibility of our combination approach for many in vivo
applications. As a matter of fact, total gene expression was still
higher for our combination pulses than for msEPs alone at extreme
electric field strength (1,040 V/cm) while the combination approach
resulted in fourfold more cell death. It suggests the increase of GET
efficiency from the combination approach overcomes the efficiency
Molecular Therapy — Methods & Clinical Development (2014) 14043
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decrease caused by additional cell death under intense msEP
parameters. This property makes our combination approach useful
for cancer gene therapy when more gene expression is needed but
cell viability is not critical.
Combined high- and low-voltage (HV+LV) electric pulses with
pulse duration under microsecond to millisecond range have been
demonstrated as an efficient GET protocol in vitro and in vivo by
several groups.14,39–41 It appears our combination pulses is quite distinctive approach in many aspects. First, both HV and LV pulses are
capable of effectively delivering DNA into cells, and either single
pulse protocol has been developed to achieve in vitro and in vivo
GET. In contrast, the successful gene transfer by nsPEFs has not
been proven. Second, HV pulse, which is applied first in the combination, can achieve effective gene expression while LV pulse may
or may not be sufficient to obtain gene transfer depending on the
parameters, then facilitates the gene transfer induced by the former
HV pulse. However, in our combination strategy, it is the msEP, the
second pulse that achieves effective gene transfer, while pretreatment with nsPEFs, which is unable to achieve any meaningful gene
expression, increase the gene transfer efficiency. Third, the influence
of the interval between two pulses on gene transfer is different. The
enhancement effect of HV+LV pulses reaches the peak with a very
short lag time microsecond to millisecond42,43 then maintains the
same level with a lag 5 seconds43 to 50 minutes42 depending on the
parameters. Nevertheless, it takes 5 minutes for cells to obtain the
maximal enhancement effect by nsPEF treatment. This enhancement is slowly diminished and can present with lag time longer
than 1 hour. Fourth, above comparisons may also suggest that the
mechanisms involved in these two combinations are different.
The mechanism behind our discovery is quite interesting. For
the HV+LV combination, it was suggested that HV pulses permeabilized cell membrane for DNA access then LV pulses electrophoretically moves DNA into cells or nuclei.43 It would be possible that
nsPEFs act in similar way by causing membrane perturbation23,26
to facilitate subsequent DNA transfer mediated by longer electric pulses. Moreover, a number of intracellular events occur after
nsPEFs, including cell swelling,44 calcium mobilization,26,27 cytoskeleton (actin) disruption,45 nuclear membrane damage,46 etc.
Several other hypothetical processes are potentially involved in
the enhancement mechanism of nsPEFs for GET. First, cell swelling,
which has been observed by Romeo et al.44 and in our experiments
(data not shown), induced by nsPEFs may increase permeabilized
membrane area for consequent DNA access. Second, intracellular
Molecular Therapy — Methods & Clinical Development (2014) 14043

changes caused by nsPEFs, including actin disassembly,45 calcium
mobilization, organelle membrane modulation, may help intracellular DNA transport to the nucleus. Third, nuclear membrane disruption46 may increase DNA diffusion but also decrease active DNA
trafficking into nucleus. Fourth, changes in the nucleus including
chromatin rearrangement46,47 could also influence DNA stability. In
this study, we were particularly interested in the role of intracellular
calcium release or extracellular calcium mobilization from nsPEFs. It
appears the enhancement effect is largely present after both intraand extracellular calcium depletion. Nevertheless, intracellular calcium release likely amplifies this enhancement since the blockage
of further increase with 5 minutes pulse interval was observed after
intracellular calcium depletion. Our data also suggest that there
are more than one mechanism involved. One of the major components is calcium independent enhancement occurring immediately
after nsPEFs and slowly diminished. Another component is calcium
dependent amplification, which is indirectly induced by nsPEFs,
reaches the maximum 5 minutes following nsPEFs. Obviously, more
studies will be needed to explore the detail mechanisms of our
combination pulses.
In conclusion, we first discovered that pretreatment but not
posttreatment with nsPEFs was critical to significantly influence
the gene expression of msEPs. We demonstrated the efficiency of
GET with msEPs could be greatly enhanced up to 40-fold by combination with nsPEFs. The kinetics of gene expression with GET was
not changed by nsPEFs under both mild and intense msEP parameters. The enhancement effects occurred immediately after nsPEFs,
reached the maximum 5 minutes later and slightly decreased at
15 minutes and could be seen after 1 hour. Cell viability was determined by both parameters of msEPs and nsPEFs. The enhancement
effect of nsPEFs is largely calcium-independent and occurs immediately after nsPEFs. However, intracellular calcium release by nsPEFs
is likely involved in time-restricted impact of nsPEFs on GET. Our
novel combination pulse approach can be utilized for the improvement of GET efficiency while higher levels of gene expression are
needed.
MATERIALS AND METHODS
Materials
The reporter plasmids encoded luciferase (gWiz-Luc) and green fluorescent
protein (gWiz-GFP) were purchased from Aldevron (Fargo, ND). CPA, a reagent
for intracellular calcium depletion, was obtained from Iurii Semennov (Old
Dominion University). D-Luciferin, which was utilized for luciferase assay or
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live cell imaging, was purchased from Goldbio Technology (St Louis, MO).
WST-1 for cell viability assay was obtained from Roche Applied Science
(Indianapolis, IN).

Cell culture
Human keratinocyte cell line (HACAT) was grown in DMEM (Cellgro,
Mediatech, VA) media with 10% FBS and antibiotics penicillin (100 U/ml) and
streptomycin (100 µg/ml) at 37 °C in an incubator under 5% CO2. Cells were
harvested for experiments while 90% confluency was reached.

into a microcentrifuge tube. After brief centrifugation, the supernatant was
transferred to a new tube. 30 µl cell lysate was mixed with 150 µl Luciferase
Assay Buffer (25 mmol/l glycylglycine, pH 7.8, 15 mmol/l KPO4, pH 7.8, 15
mmol/l MgSO4, 4 mmol/l EGTA, 2 mmol/l ATP, 1 mmol/l DTT, and 100 μmol/l
Luciferin). Luciferase activity was quantitated with a Dynex MLX microplate
luminometer (Dynex Technologies, Chantilly, VA). Serial dilutions of recombinant luciferase (Promega, Madison, WI) were utilized to make a standard
curve. Relative light unit (RLU) values were converted to luciferase activity
(pg), which was reported as total pg luciferase per million cells.

WST-1 viability assay
GET protocol
Electrotransfer was performed by using the ECM 830 Square Wave
Electroporation System (BTX, Harvard Apparatus, MA). Cells were trypsinized with trypsin-EDTA (0.05% trypsin/0.025% EDTA), washed with PBS and
suspended in complete medium or calcium free medium at a concentration
of 5 × 106/ml. After mixed with plasmid DNA (final concentration 10 µg/ml)
140 µl HACAT cell suspension was placed in a 1.25 mm gap electroporation
cuvette (BioSmith, CA). Cells were then exposed to the pulsed electric fields
with pulse duration 5 ms, frequency 1 Hz, pulse number from 1 to 16 and
applied electric field from 40 to 130 V (equal to 320–1,040 V/cm) dependent
on experiment designs. Cells were either pretreated or posttreated with
nsPEFs with interval 0 minute to 1 hour relying on the purpose of experiments. Cells were then transferred to a six-well cell culture plate (Corning
Incorporated Life Sciences, MA) and incubated in 2 ml complete medium per
well for 1–18 days for analysis dependent on the experimental designs.

Nanosecond pulsed electric fields
NsPEFs were produced by a custom-designed nanosecond pulse generator that can generate fixed 60 ns PEFs with adjustable pulse frequency and
applied electric field. The pulse profile was monitored and recorded by a digital phosphor oscilloscope (TDS3052B, Tektronix, OR) (Figure 8), and power
was provided by a high voltage power supplier (EH60R1.5, Glassman High
Voltage, NJ).
Prior to or after electrotransfer, 140 µl HACAT cells (5 × 106/ml) in a cuvette
were pulsed with nsPEFs. The pulse parameters were pulse duration 60 ns,
frequency 1 Hz, applied electric fields from 1.5 to 4 KV (equal to 12–32 KV/
cm) and pulse number 16 or 23 dependent on experimental designs. If the
interval between GET and nsPEFs was longer than 5 minutes, the cells were
re-suspended by a pipette with a 200 µl tip immediately before the second
time electric pulse delivery. Cells then were transferred, incubated and analyzed as mentioned above.

After GET with or without nsPEFs, 10 µl of cell suspension was added into a
clear-flat-bottom 96-well plate filled with 90 µl complete medium per well.
Cells were incubated at 37 °C in an incubator under 5% CO2. After 18 hour
incubation, 10 μl of WST-1 reagent was added to each well of 96-well plate.
Cells were incubated with WST-1 for 2 hours. The absorbance was measured by MultiSkan MCC/340 microplate reader (Fisher Scientific, Hampton,
NH) with a test wavelength at 450 nm and a reference wavelength at
630 nm. The cell viability was calculated with an equation: Treated sample
(OD450-OD630)/control (OD450-OD630) × 100%. 140 µl cells mixed with
same amount of DNA in a cuvette was placed into the cuvette holder for the
same duration as treated cells but no exposure to electric field as a control.

Statistical analysis
All values are reported as the mean ± SD. Analysis was completed by oneway ANOVA for many groups or two-tailed Student’s t-test for two groups.
Statistical significance was assumed at P < 0.05. All statistical analysis
was completed using the SigmaPlot 11.0 (Aspire Software International,
Ashburn, VA). For experiments with small size samples (n = 3), the statistical
analysis was justified to obtain a P < 0.05 with a power of 0.9 (PS Power and
Sample Size Calculations, Version 3.0).
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GFP expression
To observe the dynamic GFP expression, complete medium was replaced
with prewarmed PBS. Live cells on the plate were then examined by
Olympus IX71 inverted fluorescence microscopy (Olympus, Tokyo, Japan)
at different time points after GET. Pictures were captured by DP Controller
software (Version 3.1.1., Olympus).
To quantify GFP positive cells, transfected cells were harvested and resuspended in PBS with 2% FBS after gene delivery 2 days. Samples were analyzed on BD FACSAria flow cytometer (BD Biosciences, San Jose, CA). A minimum of 15,000 events was collected and the analysis of GFP expression cells
was performed with FACSDiva software (BD Biosciences).

Living imaging of luciferase expression
Live cell bioluminescence imaging was performed with the IVIS Spectrum
system (Caliper Life Sciences, Hopkinton, MA). At different time points culture medium was removed from six-well plate and replaced with 300 μl
per well prewarmed complete medium with Luciferin (300 µg/ml, Goldbio
Technology). Images were acquired 10 minutes after cells incubated with
luciferin at 37 °C. Quantitation of luciferase activity was analyzed with the
Living Image acquisition and analysis software (Caliper Life Sciences).

Luciferase assay
Luciferase activity was quantified as the following steps. Growth medium
was removed from six-well plates 18 hours after GET. Cells were washed with
2 ml 1× PBS twice. 250 µl Cell Culture Lysis Reagent (CCLR) was dispersed
into each well. Cells were scraped and transferred together with solution
© 2014 The American Society of Gene & Cell Therapy

References
1. Heller, LC and Heller, R (2006). In vivo electroporation for gene therapy. Hum Gene Ther
17: 890–897.
2. Gothelf, A and Gehl, J (2010). Gene electrotransfer to skin; review of existing literature
and clinical perspectives. Curr Gene Ther 10: 287–299.
3. Murakami, T and Sunada, Y (2011). Plasmid DNA gene therapy by electroporation:
principles and recent advances. Curr Gene Ther 11: 447–456.
4. Somiari, S, Glasspool-Malone, J, Drabick, JJ, Gilbert, RA, Heller, R, Jaroszeski, MJ et al.
(2000). Theory and in vivo application of electroporative gene delivery. Mol Ther 2: 178–
187.
5. Trezise, AE, Palazon, L, Davies, WL and Colledge, WH (2003). In vivo gene expression: DNA
electrotransfer. Curr Opin Mol Ther 5: 397–404.
6. Andre, FM and Mir, LM (2010). Nucleic acids electrotransfer in vivo: mechanisms and
practical aspects. Curr Gene Ther 10: 267–280.
7. Daud, AI, DeConti, RC, Andrews, S, Urbas, P, Riker, AI, Sondak, VK et al. (2008). Phase I trial
of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin
Oncol 26: 5896–5903.
8. Samakoglu, S, Fattori, E, Lamartina, S, Toniatti, C, Stockholm, D, Heard, JM et al. (2001).
betaMinor-globin messenger RNA accumulation in reticulocytes governs improved
erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA
electrotransfer in muscles. Blood 97: 2213–2220.
9. Celiker, MY, Ramamurthy, N, Xu, JW, Wang, M, Jiang, Y, Greenwald, R et al. (2002). Inhibition
of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene
delivery. Arthritis Rheum 46: 3361–3368.
10. Bodles-Brakhop, AM, Heller, R and Draghia-Akli, R (2009). Electroporation for the delivery
of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol
Ther 17: 585–592.

Molecular Therapy — Methods & Clinical Development (2014) 14043

Enhancement of gene electrotransfer by nsPEFs
S Guo et al.

8
11. Misra, A, Ganga, S and Upadhyay, P (1999). Needle-free, non-adjuvanted skin
immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid
and a candidate peptide vaccine against hepatitis B virus. Vaccine 18: 517–523.
12. Ferraro, B, Cruz, YL, Coppola, D and Heller, R (2009). Intradermal delivery of plasmid
VEGF(165) by electroporation promotes wound healing. Mol Ther 17: 651–657.
13. Marti, G, Ferguson, M, Wang, J, Byrnes, C, Dieb, R, Qaiser, R et al. (2004). Electroporative
transfection with KGF-1 DNA improves wound healing in a diabetic mouse model. Gene
Ther 11: 1780–1785.
14. André, FM, Gehl, J, Sersa, G, Préat, V, Hojman, P, Eriksen, J et al. (2008). Efficiency of highand low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and
skin. Hum Gene Ther 19: 1261–1271.
15. Cemazar, M, Golzio, M, Sersa, G, Escoffre, JM, Coer, A, Vidic, S et al. (2012). Hyaluronidase
and collagenase increase the transfection efficiency of gene electrotransfer in various
murine tumors. Hum Gene Ther 23: 128–137.
16. Glasspool-Malone, J and Malone, RW (1999). Marked enhancement of direct respiratory
tissue transfection by aurintricarboxylic acid. Hum Gene Ther 10: 1703–1713.
17. Henshaw, J, Mossop, B and Yuan, F (2008). Relaxin treatment of solid tumors: effects on
electric field-mediated gene delivery. Mol Cancer Ther 7: 2566–2573.
18. Rebersek, M, Faurie, C, Kanduser, M, Corovic, S, Teissié, J, Rols, MP et al. (2007).
Electroporator with automatic change of electric field direction improves gene
electrotransfer in-vitro. Biomed Eng Online 6: 25.
19. Schoenbach, KH, Peterkin, FE, Alden, RW 3rd and Beebe, SJ (1997). The effect of pulsed
electric fields on biological cells: experiments and applications. IEEE Transactions on
Plasma Science 25: 284–292.
20. Gowrishankar, TR, Stewart, DA and Weaver, JC (2006). Model of a confined spherical cell
in uniform and heterogeneous applied electric fields. Bioelectrochemistry 68: 181–190.
21. Joshi, RP, Hu, Q and Schoenbach, KH (2004). Modeling studies of cell response to
ultrashort, high-intensity electric fields—implications for intracellular manipulation.
IEEE Transactions on Plasma Science 32: 1677–1686.
22. Ibey, BL, Xiao, S, Schoenbach, KH, Murphy, MR and Pakhomov, AG (2009). Plasma
membrane permeabilization by 60- and 600-ns electric pulses is determined by the
absorbed dose. Bioelectromagnetics 30: 92–99.
23. Pakhomov, AG, Kolb, JF, White, JA, Joshi, RP, Xiao, S and Schoenbach, KH (2007). Longlasting plasma membrane permeabilization in mammalian cells by nanosecond pulsed
electric field (nsPEF). Bioelectromagnetics 28: 655–663.
24. Tekle, E, Oubrahim, H, Dzekunov, SM, Kolb, JF, Schoenbach, KH and Chock, PB (2005).
Selective field effects on intracellular vacuoles and vesicle membranes with nanosecond
electric pulses. Biophys J 89: 274–284.
25. Schoenbach, KH, Beebe, SJ and Buescher, ES (2001). Intracellular effect of ultrashort
electrical pulses. Bioelectromagnetics 22: 440–448.
26. Vernier, PT, Sun, Y, Marcu, L, Salemi, S, Craft, CM and Gundersen, MA (2003). Calcium
bursts induced by nanosecond electric pulses. Biochem Biophys Res Commun 310: 286–
295.
27. White, JA, Blackmore, PF, Schoenbach, KH and Beebe, SJ (2004). Stimulation of
capacitative calcium entry in HL-60 cells by nanosecond pulsed electric fields. J Biol
Chem 279: 22964–22972.
28. Ford, WE, Ren, W, Blackmore, PF, Schoenbach, KH and Beebe, SJ (2010). Nanosecond
pulsed electric fields stimulate apoptosis without release of pro-apoptotic factors from
mitochondria in B16f10 melanoma. Arch Biochem Biophys 497: 82–89.
29. Beebe, SJ, Fox, PM, Rec, LJ, Somers, K, Stark, RH and Schoenbach, KH (2002). Nanosecond
pulsed electric field (nsPEF) effects on cells and tissues: apoptosis induction and tumor
growth inhibition. IEEE Transactions on Plasma Science 30: 286–292.
30. Beebe, SJ, Fox, PM, Rec, LJ, Willis, EL and Schoenbach, KH (2003). Nanosecond, highintensity pulsed electric fields induce apoptosis in human cells. FASEB J 17: 1493–1495.
31. Garon, EB, Sawcer, D, Vernier, PT, Tang, T, Sun, Y, Marcu, L et al. (2007). In vitro and in vivo
evaluation and a case report of intense nanosecond pulsed electric field as a local
therapy for human malignancies. Int J Cancer 121: 675–682.
32. Nuccitelli, R, Chen, X, Pakhomov, AG, Baldwin, WH, Sheikh, S, Pomicter, JL et al. (2009). A
new pulsed electric field therapy for melanoma disrupts the tumor’s blood supply and
causes complete remission without recurrence. Int J Cancer 125: 438–445.

33. Silve, A, Leray, I and Mir, LM (2012). Demonstration of cell membrane permeabilization to
medium-sized molecules caused by a single 10 ns electric pulse. Bioelectrochemistry 87:
260–264.
34. Beebe, SJ, Blackmore, PF, White, J, Joshi, RP and Schoenbach, KH (2004). Nanosecond
pulsed electric fields modulate cell function through intracellular signal transduction
mechanisms. Physiol Meas 25: 1077–1093.
35. Chopinet, L, Batista-Napotnik, T, Montigny, A, Rebersek, M, Teissié, J, Rols, MP et al. (2013).
Nanosecond electric pulse effects on gene expression. J Membr Biol 246: 851–859.
36. Beebe, SJ, White, J, Blackmore, PF, Deng, Y, Somers, K and Schoenbach, KH (2003). Diverse
effects of nanosecond pulsed electric fields on cells and tissues. DNA Cell Biol 22: 785–
796.
37. Fukumura, D, Xavier, R, Sugiura, T, Chen, Y, Park, EC, Lu, N et al. (1998). Tumor induction of
VEGF promoter activity in stromal cells. Cell 94: 715–725.
38. Markelc, B, Tevz, G, Cemazar, M, Kranjc, S, Lavrencak, J, Zegura, B et al. (2012). Muscle
gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther 19: 312–
320.
39. Kanduser, M, Miklavcic, D and Pavlin, M (2009). Mechanisms involved in gene
electrotransfer using high- and low-voltage pulses–an in vitro study. Bioelectrochemistry
74: 265–271.
40. Pavselj, N and Préat, V (2005). DNA electrotransfer into the skin using a combination of
one high- and one low-voltage pulse. J Control Release 106: 407–415.
41. Stroh, T, Erben, U, Kühl, AA, Zeitz, M and Siegmund, B (2010). Combined pulse
electroporation–a novel strategy for highly efficient transfection of human and mouse
cells. PLoS ONE 5: e9488.
42. Satkauskas, S, Bureau, MF, Puc, M, Mahfoudi, A, Scherman, D, Miklavcic, D et al.
(2002). Mechanisms of in vivo DNA electrotransfer: respective contributions of cell
electropermeabilization and DNA electrophoresis. Mol Ther 5: 133–140.
43. Sukharev, SI, Klenchin, VA, Serov, SM, Chernomordik, LV and Chizmadzhev YuA,
(1992). Electroporation and electrophoretic DNA transfer into cells. The effect of DNA
interaction with electropores. Biophys J 63: 1320–1327.
44. Romeo, S, Wu, YH, Levine, ZA, Gundersen, MA and Vernier, PT (2013). Water influx and
cell swelling after nanosecond electropermeabilization. Biochim Biophys Acta 1828:
1715–1722.
45. Pakhomov, AG, Xiao, S, Pakhomova, ON, Semenov, I, Kuipers, MA and Ibey, BL (2014).
Disassembly of actin structures by nanosecond pulsed electric field is a downstream
effect of cell swelling. Bioelectrochemistry. (epub ahead of print).
46. Stacey, M, Fox, P, Buescher, S and Kolb, J (2011). Nanosecond pulsed electric field induced
cytoskeleton, nuclear membrane and telomere damage adversely impact cell survival.
Bioelectrochemistry 82: 131–134.
47. Vernier, PT, Sun, Y, Wang, J, Thu, MM, Garon, E, Valderrabano, M et al. (2005).
Nanoelectropulse intracellular perturbation and electropermeabilization technology:
phospholipid translocation, calcium bursts, chromatin rearrangement, cardiomyocyte
activation, and tumor cell sensitivity. Conf Proc IEEE Eng Med Biol Soc 6: 5850–5853.

This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivs 3.0 Unported License. The images or other
third party material in this article are included in the article’s Creative Commons license,
unless indicated otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from the license holder to
reproduce the material. To view a copy of this license, visit http://creativecommons.org/
licenses/by-nc-nd/3.0/

Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)

Molecular Therapy — Methods & Clinical Development (2014) 14043

© 2014 The American Society of Gene & Cell Therapy

